• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同测试地点熟练度测试表现的差异。

Variation in proficiency testing performance by testing site.

作者信息

Stull T M, Hearn T L, Hancock J S, Handsfield J H, Collins C L

机构信息

Centers for Disease Control and Prevention, Public Health Practice Program Office, Division of Laboratory Systems, Atlanta, Ga 30341, USA.

出版信息

JAMA. 1998 Feb 11;279(6):463-7. doi: 10.1001/jama.279.6.463.

DOI:10.1001/jama.279.6.463
PMID:9466641
Abstract

CONTEXT

Congress enacted the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to promote uniform quality and standards among all testing sites in the United States. The performance indicators specified in the legislation are proficiency testing (PT) performance and periodic inspections.

OBJECTIVE

To evaluate variation in PT performance by type of testing facility during the first year of compulsory participation under CLIA.

DESIGN

All 1994 PT score data electronically reported to the Health Care Financing Administration as a component of compliance with the CLIA regulations were obtained. Over 1.2 million PT event scores from 17058 unique testing sites were sorted into 2 groups based on the type of testing facility: hospitals and independent laboratories (HI) and all other testing sites (AOT).

MAIN OUTCOME MEASURES

Satisfactory and unsatisfactory performance rates for HI and AOT for each analyte and/or test, according to the criteria specified by the CLIA regulations.

RESULTS

The aggregate rates of satisfactory event performance for all regulated analytes, tests, and specialties were 97% and 91% for the HI and AOTgroups, respectively. The aggregate odds ratio for unsatisfactory PT event performance for the AOT group compared with the HI group was 2.89, with a range of 2.19 to 7.51 for the individual analytes.

CONCLUSION

There was a consistent difference in PT performance during the first full year of compulsory PT under the CLIA regulations based on the type of testing facility performing the analysis. Traditional testing sites achieved higher rates of satisfactory performance than newly regulated, alternative testing sites.

摘要

背景

美国国会颁布了1988年《临床实验室改进修正案》(CLIA),以促进美国所有检测场所的质量和标准统一。该立法规定的绩效指标是能力验证(PT)表现和定期检查。

目的

评估在CLIA强制参与的第一年中,不同类型检测机构的PT表现差异。

设计

获取了1994年所有以电子方式报告给医疗保健财务管理局的PT分数数据,作为符合CLIA法规的一部分。来自17058个不同检测场所的超过120万个PT项目分数,根据检测机构类型分为两组:医院和独立实验室(HI)以及所有其他检测场所(AOT)。

主要观察指标

根据CLIA法规规定的标准,HI和AOT在每种分析物和/或检测中的满意和不满意表现率。

结果

所有受监管分析物、检测和专业的满意项目表现总率,HI组和AOT组分别为97%和91%。AOT组与HI组相比,PT项目表现不满意的总体优势比为2.89,单个分析物的范围为2.19至7.51。

结论

根据进行分析的检测机构类型,在CLIA法规强制进行PT的第一个完整年度中,PT表现存在持续差异。传统检测场所的满意表现率高于新受监管的替代检测场所。

相似文献

1
Variation in proficiency testing performance by testing site.不同测试地点熟练度测试表现的差异。
JAMA. 1998 Feb 11;279(6):463-7. doi: 10.1001/jama.279.6.463.
2
Proficiency testing performance in US laboratories: results reported to the Centers for Medicare & Medicaid Services, 1994 through 2006.美国实验室的能力验证表现:1994 年至 2006 年向医疗保险和医疗补助服务中心报告的结果。
Arch Pathol Lab Med. 2010 May;134(5):751-8. doi: 10.5858/134.5.751.
3
Clinical laboratory performance on proficiency testing samples--United States, 1994.1994年美国临床实验室对能力验证样本的检测表现
MMWR Morb Mortal Wkly Rep. 1996 Mar 8;45(9):193-6.
4
Medicare, Medicaid and CLIA programs; revision of the laboratory regulations for the Medicare, Medicaid, and Clinical Laboratories Improvement Act of 1967 programs--HCFA. Final rule with comment period.医疗保险、医疗补助和临床实验室改进修正案(CLIA)计划;修订1967年《医疗保险、医疗补助和临床实验室改进法案》计划的实验室法规——医疗保健财务管理局(HCFA)。附意见征求期的最终规则。
Fed Regist. 1990 Mar 14;55(50):9538-610.
5
CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Final rule.临床实验室改进修正案(CLIA)计划;简化与认证、州许可计划下实验室的豁免、能力验证和检查相关的CLIA法规——医疗保健财务管理局(HCFA)。最终规则。
Fed Regist. 1998 May 14;63(93):26722-38.
6
CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Correction.临床实验室改进修正案(CLIA)计划;简化与认证、州许可计划下实验室的豁免、能力验证和检查相关的CLIA法规——医疗保健财务管理局(HCFA)。更正。
Fed Regist. 1998 Jun 15;63(114):32699.
7
Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)--HCFA. Final rule with comment period.医疗保险、医疗补助和临床实验室改进修正案(CLIA)计划;实施1988年《临床实验室改进修正案》(CLIA)的法规——医疗保健财务管理局。附意见征求期的最终规则。
Fed Regist. 1992 Feb 28;57(40):7002-186.
8
Has compliance with CLIA requirements really improved quality in US clinical laboratories?遵守临床实验室改进修正案(CLIA)的要求真的提高了美国临床实验室的质量吗?
Clin Chim Acta. 2004 Aug 2;346(1):37-43. doi: 10.1016/j.cccn.2003.12.033.
9
A foundation for PT (proficiency test) success.
MLO Med Lab Obs. 1999 Feb;31(2):44-8.
10
Regulations for implementing the Clinical Laboratory Improvement Amendments of 1988: a summary.《1988年临床实验室改进修正案》实施条例摘要
MMWR Recomm Rep. 1992 Feb 28;41(RR-2):1-17.

引用本文的文献

1
35 years after CLIA 1988: Key insights and policy implications among laboratory professionals.CLIA 1988 实施 35 年后:实验室专业人员的重要见解和政策启示。
PLoS One. 2024 Sep 27;19(9):e0311251. doi: 10.1371/journal.pone.0311251. eCollection 2024.
2
Implementing blind proficiency testing in forensic laboratories: Motivation, obstacles, and recommendations.法医实验室实施盲法能力验证:动机、障碍及建议。
Forensic Sci Int Synerg. 2020 Sep 24;2:293-298. doi: 10.1016/j.fsisyn.2020.09.002. eCollection 2020.
3
Accuracy in HIV Rapid Testing among Laboratory and Non-laboratory Personnel in Zambia: Observations from the National HIV Proficiency Testing System.
赞比亚实验室及非实验室工作人员中HIV快速检测的准确性:来自国家HIV能力验证检测系统的观察结果
PLoS One. 2016 Jan 8;11(1):e0146700. doi: 10.1371/journal.pone.0146700. eCollection 2016.
4
Laboratory Diagnostics Market in East Africa: A Survey of Test Types, Test Availability, and Test Prices in Kampala, Uganda.东非实验室诊断市场:乌干达坎帕拉的检测类型、检测可及性及检测价格调查
PLoS One. 2015 Jul 30;10(7):e0134578. doi: 10.1371/journal.pone.0134578. eCollection 2015.
5
Evaluation of analytical errors in a clinical chemistry laboratory: a 3 year experience.临床化学实验室分析误差评估:三年经验总结
Ann Med Health Sci Res. 2015 Jan-Feb;5(1):8-12. doi: 10.4103/2141-9248.149763.
6
Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008.1994 年至 2008 年美国实验室结核药物敏感性检测的表现。
J Clin Microbiol. 2012 Apr;50(4):1233-9. doi: 10.1128/JCM.06479-11. Epub 2012 Feb 1.
7
Three-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population.基于转录介导扩增的阴道毛滴虫分析物特异性试剂检测在亚急性护理患者人群中的三年历史。
J Clin Microbiol. 2011 Dec;49(12):4190-4. doi: 10.1128/JCM.05632-11. Epub 2011 Oct 12.
8
Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence.阴道毛滴虫转录介导扩增法分析物特异性试剂检测在性传播疾病高流行的大都市环境中的影响
J Clin Microbiol. 2008 Oct;46(10):3368-74. doi: 10.1128/JCM.00564-08. Epub 2008 Aug 27.
9
Evaluation of mycology laboratory proficiency testing.真菌学实验室能力验证评估。
J Clin Microbiol. 1999 Jul;37(7):2297-305. doi: 10.1128/JCM.37.7.2297-2305.1999.